Total Intravenous Anaesthesia (TIVA) Versus Spinal Anaesthesia in Patients Undergoing Transurethral Prostate Resection

NCT ID: NCT01118260

Last Updated: 2010-05-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-01-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of total intravenous anaesthesia with spinal anaesthesia in patients undergoing transurethral prostate resection

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Comparison of total intravenous anaesthesia with spinal anaesthesia in patients undergoing transurethral prostate resection regarding patient satisfaction and discharge time

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prostate Hyperplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TIVA

Total intravenous anaesthesia (TIVA) with propofol and remifentanil

Group Type ACTIVE_COMPARATOR

total intravenous anaesthesia

Intervention Type PROCEDURE

propofol and remifentanil

Spinal

Spinal anaesthesia with bupivacaine and fentanyl

Group Type ACTIVE_COMPARATOR

spinal anaesthesia

Intervention Type PROCEDURE

bupivacaine and fentanyl

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

total intravenous anaesthesia

propofol and remifentanil

Intervention Type PROCEDURE

spinal anaesthesia

bupivacaine and fentanyl

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years and older
* signed informed consent
* elective transurethral prostata resection

Exclusion Criteria

* ASA more than 3
* kidney disease, liver disease
* intolerance against bupivacaine, fentanyl, propofol og remifentanil
* chronic pulmonary disease
* dementia
Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asker & Baerum Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Asker & Baerum Hospital, Vestre Viken HF

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vegard Dahl, MD, PhD

Role: STUDY_CHAIR

Asker & Baerum Hospital

Elisabet Andersson

Role: PRINCIPAL_INVESTIGATOR

Asker & Baerum Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asker & Baerum Hospital

Rud, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2004-002672-42

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Enhanced Recovery After Urologic Surgery
NCT06789744 NOT_YET_RECRUITING NA